Dr. Erik P. Castle spoke at the 23rd annual Perspectives in Urology Point • Counterpoint meeting on Saturday, November 15, 2014 on “Treatment Options for the Small Renal Mass.”


Keywords: renal cell carcinoma, nephron sparing, clinical studies

How to cite: Castle, Erik P. “Treatment Options for the Small Renal Mass” Grand Rounds in Urology. November 15, 2014. Accessed Oct 2022. https://dev.grandroundsinurology.com/renal-cancer-erik-p-castle-small-renal-masses/.


Bijol V, Mendez GP, Hurwitz S, et al. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol. 2006 May;30(5):575-84.

Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009 Oct;182(4):1271-9.

Huang WC, Levey AS, Serio AM, et al.
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006 Sep;7(9):735-40.

Lau WK, Blute ML, Weaver AL, et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000 Dec;75(12):1236-42.

McKiernan J, Simmons R, Katz J, et al. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2002 Jun;59(6):816-20.

Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008 Feb;179(2):468-71; discussion 472-3.